The Global Medical Elastomers Market Growth Accelerated By Increasing Adoption In Medical Devices

 

Medical Elastomers Market

Medical elastomers are synthetic polymers that have elastic properties similar to natural rubber and are commonly used in medical devices and equipment. They are used to produce items like catheters, surgical gloves, implantable devices, blood containers and orthopedic devices. Medical elastomers offer properties like flexibility, elasticity and resistance to chemicals & radiation which makes them suitable for a variety of medical applications.

The global Medical Elastomers Market is estimated to be valued at US$ 8223.86 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Dynamics:

Increasing demand of elastomers in medical devices is the primary driver fueling growth of the medical elastomers market. The expanding medical device industry globally has increased procurement of elastomers for production of various devices. According to estimates, the global medical device industry was valued at nearly US$ 425 Bn in 2019 and is projected to witness a CAGR of 4.6% during 2020-2027.Growing prevalence of chronic diseases is another key factor augmenting market growth. Chronic diseases require long-term care which involves diagnostic tests and surgeries. This has boosted production of devices like catheters, medical tubing, and components which employ large amounts of medical elastomers. Furthermore, ongoing research & development of elastomers with enhanced properties suitable for innovative medical applications acts as an opportunities for market players over the forecast period.

 

SWOT Analysis

 

Strength: Medical elastomers have high compatibility with tissues and fluids in the human body, making them suitable for medical applications requiring flexibility and durability. Their elastic properties allow for minimal particle shedding and provide comfort for patients. Manufacturers are continuously investing in R&D to develop medical elastomers with improved mechanical properties.

 

Weakness: The production process of medical elastomers can be complex and requires stringent quality controls, driving up costs. Raw material price volatility also affects the overall costs. Certain compounds may have limited resistance to chemicals and heat over long durations of exposure inside the body.

 

Opportunity: Rising healthcare expenditure and increasing global disease burden are fueling the demand for various medical devices that use elastomers. The growing geriatric population prone to chronic conditions widens the market scope. Regulations supporting localized production of medical goods in certain countries presents new revenue avenues.

 

Threats: Stringent medical device regulations across regions necessitate extensive clinical testing before products can be commercialized. This poses delays and financial hurdles for players. Substitution threat exists from alternative biomaterials with better biocompatibility and mechanical profiles.

 

Key Takeaways

 

The Global Medical Elastomers Market Share is expected to witness high growth over the forecast period of 2023 to 2030. The global Medical Elastomers Market is estimated to be valued at US$ 8223.86 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030.

Regional analysis shows that North America currently dominates the market, attributed to continuous investments in R&D and presence of key players. Europe and Asia Pacific are rapidly emerging markets with growing medical infrastructure and demand for healthcare services.

 

Key players operating in the Medical Elastomers market are AB-Cube, AssurX, Oracle, Sarjen Systems, Sparta Systems, Xybion, ZEINCRO, Omnify Software, INTEL, MDI Consultants, and Numerix. AB-Cube is a prominent manufacturer focusing on silicone and thermoplastic polyurethane compounds for surgical devices, implants, tubing, etc. AssurX provides medical device software for compliant product design, development, and maintenance.


Get More Insights Here

 

https://www.newsstatix.com/medical-elastomers-market-size-share-growth-outlook-2023/

Comments

Post a Comment

Popular posts from this blog

"Global Heparin Market: Current Trends and Future Prospects"

Image
  Heparin, a crucial anticoagulant, has been a mainstay in the pharmaceutical industry for many years. It plays a pivotal role in preventing and treating conditions such as deep vein thrombosis, pulmonary embolism, and various cardiovascular diseases. As we delve into the current state of the heparin market, we will explore the trends, challenges, and opportunities that shape this vital segment of the pharmaceutical industry. Market Overview: The global heparin market has experienced steady growth over the years, driven by an aging population, increasing cases of cardiovascular diseases, and a rising awareness of the importance of anticoagulants in healthcare. Heparin is available in various forms, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH), each with its own set of applications and market dynamics. Trends: 1.      Rising Demand for LMWH : Low molecular weight heparin is gaining popularity due to its ease of administr...
Read more

"Advancements in Cystic Fibrosis Treatment: A Comprehensive Market Analysis"

Image
  The cystic fibrosis market has seen significant advancements and changes in recent years. Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to thick and sticky mucus production that can cause serious respiratory and digestive complications. The introduction of new therapies and treatments, such as CFTR modulators, has revolutionized the management of cystic fibrosis, offering hope and improved quality of life for patients. These drugs target the underlying genetic mutations responsible for the condition, helping to alleviate symptoms and slow disease progression. However, challenges remain in the cystic fibrosis market . Access to these ground-breaking therapies can be limited due to high costs, and ongoing research is needed to develop treatments for all genetic mutations associated with the disease. Additionally, the market continues to evolve as new therapies and innovations emerge. Collaborative efforts between pharmaceutical compani...
Read more

Botanical Packaging is Estimated to Witness High Growth Owing to Growing Environmental Concerns

Image
  Botanical Packaging Market Botanical packaging involves using various plant-based materials like corn starch, wheat starch, soy protein, bamboo, bagasse as raw materials for manufacturing boxes, cartons, bags and wrapping films for packaging applications. These biodegradable materials offer attractive sustainability advantages over traditional petroleum-based plastics. Botanical packaging finds widespread application in food, beverage, pharmaceutical, personal care and homecare industries for primary, secondary and tertiary packaging needs. The global botanical packaging Market is estimated to be valued at US$ 138.24 Bn in 2023 and is expected to exhibit a CAGR of 34% over the forecast period 2024 to 2031.   Market Dynamics: Growing environmental concerns about the menace of plastic pollution have been fuelling adoption of sustainable packaging alternatives globally. One of the key drivers for botanical packaging market is the stringent government policies and regulati...
Read more